Translational Regenerative Medicine Market Top Companies Analysis To growing at CAGR of 12.13% by 20 – PharmiWeb.com
stemadminBenefits Of Stem CellsNo comments

Pune, Maharashtra, India, December 10 2020 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd :Translational Regenerative MedicineMarket is valued at USD 216.00 Million in 2018 and expected to reach USD 481.40 Million by 2025 with the CAGR of 12.13% over the forecast period. Scope ofTranslational Regenerative MedicineMarket Translational regenerative medicine very broad, new approach to medicine which uses the advances in stem cell technology. These medicines make the use of stem cell to provide clinical care is an area to fully heal damaged tissues and organs, offer solutions to critical conditions and to the damage which is beyond repair

Read more
3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions : Industry Trends and Global Forecasts,…
stemadminBenefits Of Stem CellsNo comments

New York, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions : Industry Trends and Global Forecasts, 2020-2030" - https://www.reportlinker.com/p05995354/?utm_source=GNW However, over time, it has been demonstrated that such cultures are unable to accurately mimic the natural (in vivo) microenvironment.

Read more
Could Gene Therapy Be Used To Mimic the Positive Effects of Exercise? – Technology Networks
stemadminBenefits Of Stem CellsNo comments

It sounds too good to be true - and it is. But Jose Bianco Moreira and the CERG research group at the Norwegian University of Science and Technology (NTNU) are convinced that some of the positive health effects of physical exercise can be achieved using gene therapy and medication. "We're not talking about healthy people and everyone who can exercise.

Read more
Test-Tube-Treat: The Future Of Lab-Grown Meat – Impact Magazine – Impact Magazine
stemadminBenefits Of Stem CellsNo comments

Phoebe Raine With 2020 being the year of dystopia becoming reality, Singapores decision to approve chicken meat grown in a lab poses some interesting questions about the future of feeding our growing population. No eyes or beak or anything, they dont need thosethis thing feels no pain says a scientist in Atwoods dystopian fiction Oryx and Crake, referring to the headless, pulsating chicken mass that makes chickienobs, a lab-created chicken product.

Read more
BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium – BioSpace
stemadminBenefits Of Stem CellsNo comments

NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- BeyondSpring (the Company or BeyondSpring) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced the new data from its Phase 3 PROTECTIVE-2 Study 106 demonstrating that plinabulin in combination with pegfilgrastim offers greater protection against chemotherapy-induced neutropenia (CIN) than the standard of care, pegfilgrastim alone. The study not only met the primary and key secondary objectives, as previously disclosed on Nov.

Read more
Dr. Kansagra: Quadruplet Therapy for Newly Diagnosed Multiple Myeloma and Combination CAR T-Cell Opportunities – DocWire News
stemadminBenefits Of Stem CellsNo comments

Ankit Kansagra, MD, an assistant professor in theDepartment of Internal Medicineat UT Southwestern Medical Center and assistant director of theOutpatient Stem Cell Transplant Program, talks about the potential for changes to combination therapy for multiple myeloma (MM) with the approval of chimeric antigen receptor T-cell agents and the introduction of quadruplet therapy. In part three of this interview with Dr. Kansagra, available December 15, he discusses newly approved therapies for MM and highlights drugs in the pipeline

Read more
Negrin Shines Light on the Orca-T Story in GVHD – OncLive
stemadminBenefits Of Stem CellsNo comments

What started out as a journey to better understand regulatory T cells has now led to an intriguing approach with an investigational cell therapy designed to prevent the risk of graft-versus-host disease (GVHD) and to improve relapse-free survival rates in patients undergoing hematopoietic stem cell transplantation (HSCT). Data of a phase 1/2 trial recently showed that the first-generation precision cell treatment Orca-T compared with a historical control of standard HSCT demonstrated faster neutrophil (median, 12 days vs 14 days; P < .0001) and platelet engraftment (median, 11 days vs 17 days; P < .0001), decreased incidence of grade 2 or higher GVHD at 100 days (10% vs 30%, P = .005) and chronic GVHD at 1 year (3% vs 46%, P = .0002).1,2 The 1-year GVHD-free and GVHD relapse-free survival (GRFS) rates were 75% with the use of Orca-T vs 31% with standard HSCT (P < .0001). The comparator cohort was derived from contemporaneous patients who had been treated at Stanford University with a conventional allograft

Read more
Genetic engineering transformed stem cells into working mini-livers that extended the life of mice with liver disease – CT Post
stemadminBenefits Of Stem CellsNo comments

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE CONVERSATION) Takeaways - Scientists have made progress growing human liver in the lab. - The challenge has been to direct stems cells to grow into a mature, functioning adult organ.

Read more

Theme: Illdy.